These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1715689)

  • 21. Regional and subcellular distribution of [125I]endothelin binding sites in rat brain.
    Bolger GT; Berry R; Jaramillo J
    Brain Res Bull; 1992 May; 28(5):789-97. PubMed ID: 1319799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.
    Reeve JG; Bleehen NM
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1313-9. PubMed ID: 7511895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A synthetic peptide that is a bombesin receptor antagonist.
    Jensen RT; Jones SW; Folkers K; Gardner JD
    Nature; 1984 May 3-9; 309(5963):61-3. PubMed ID: 6201745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
    Nambi P; Wu HL; Pullen M; Aiyar N; Bryan H; Elliott J
    Mol Pharmacol; 1992 Aug; 42(2):336-9. PubMed ID: 1325032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antagonism of bombesin in the CNS by substance P analogues.
    Yachnis AT; Crawley JN; Jensen RT; McGrane MM; Moody TW
    Life Sci; 1984 Nov; 35(19):1963-9. PubMed ID: 6208451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the endothelin receptors of rat myometrial plasma membranes.
    Atke A; Vilhardt H
    J Recept Res; 1991; 11(1-4):283-92. PubMed ID: 1653334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of a substance P antagonist, [D-Arg1,D-Pro2,D-Trp7,9,Leu11]-substance P.
    Watson SP
    Br J Pharmacol; 1983 Sep; 80(1):205-9. PubMed ID: 6197127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
    Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
    Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific receptor for endothelin in cultured rat cardiocytes.
    Hirata Y; Fukuda Y; Yoshimi H; Emori T; Shichiri M; Marumo F
    Biochem Biophys Res Commun; 1989 May; 160(3):1438-44. PubMed ID: 2543401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-linking of endothelin 1 and endothelin 3 to rat brain membranes: identification of the putative receptor(s).
    Ambar I; Kloog Y; Sokolovsky M
    Biochemistry; 1990 Jul; 29(27):6415-8. PubMed ID: 2169870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Streptozotocin-induced diabetes reduces the density of [125I]-endothelin-binding sites in rat cardiac membranes.
    Nayler WG; Liu JJ; Panagiotopoulos S; Casley DJ
    Br J Pharmacol; 1989 Aug; 97(4):993-5. PubMed ID: 2676060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands.
    Nambi P; Pullen M; Wu HL; Aiyar N; Ohlstein EH; Edwards RM
    Endocrinology; 1992 Sep; 131(3):1081-6. PubMed ID: 1324149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of endothelin receptors in various regions of rat brain.
    Nambi P; Pullen M; Feuerstein G
    Neuropeptides; 1990 Aug; 16(4):195-9. PubMed ID: 2177164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of substance P and substance P antagonists on rat salivary secretion.
    Bobyock E; Barbieri EJ; Chernick WS
    J Dent Res; 1986 Dec; 65(12):1427-31. PubMed ID: 2431018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadmium directly acts on endothelin receptor and inhibits endothelin binding activity.
    Wada K; Fujii Y; Watanabe H; Satoh M; Furuichi Y
    FEBS Lett; 1991 Jul; 285(1):71-4. PubMed ID: 1648515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of anti-endothelin receptor monoclonal antibodies for use in receptor characterization.
    Kondoh M; Miyazaki H; Watanabe H; Shibata T; Yanagisawa M; Masaki T; Murakami K
    Biochem Biophys Res Commun; 1990 Oct; 172(2):503-10. PubMed ID: 2173568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranes.
    Waugh CJ; Dockrell ME; Haynes WG; Olverman HJ; Williams BC; Webb DJ
    Biochem Biophys Res Commun; 1992 Jun; 185(2):630-5. PubMed ID: 1610355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
    Jones DA; Cummings J; Langdon SP; Maclellan AJ; Higgins T; Rozengurt E; Smyth JF
    Br J Cancer; 1996 Mar; 73(6):715-20. PubMed ID: 8611370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.